29 November 2024
The TOLIFE project, now two years in, has published its second press release, highlighting the successful development of non-invasive devices and the commencement of Clinical Study A. This pivotal phase marks a significant step toward revolutionizing COPD care through AI-driven, personalized solutions.
Read the full press release to discover how these innovations are shaping the future of chronic disease management.
01 October 2024
On September 27, 2024, TOLIFE proudly participated in the European Researchers’ Night, known as BRIGHT-NIGHT, a prestigious event organized across Europe. This initiative, created by the European Commission, aims to promote scientific culture and showcase the societal impact of research.
BRIGHT-NIGHT stands for Brilliant Researchers Impact on Growth Health and Trust in research, highlighting the crucial role that talented researchers play in advancing science and fostering public trust. It serves as an opportunity for people of all ages to connect with the world of science and meet the dedicated individuals who have made research their daily mission.
In Padua, the CNR (National Research Council) participated, presenting cutting-edge developments in science and innovation, including the devices from the TOLIFE project. These devices were showcased to the public, offering an up-close look at the groundbreaking technology designed to improve health and well-being.
TOLIFE’s involvement in this significant event underlines the project’s commitment to impactful research and its dedication to enhancing quality of life through innovative scientific solutions. BRIGHT-NIGHT was not only an inspiring celebration of research but also a step forward in bringing science closer to communities and sparking curiosity about the world of discovery.
28 September 2024
The TOLIFE project convened its General Assembly at the Universidad Politécnica de Madrid on September 25-26, bringing together researchers, project partners, and patient representatives to assess the progress and define future strategies.
The first day began with presentations on key Work Packages, focusing on Project Management, Communication, and the development of critical components such as Analytics Tools, Smart Sensors, and the Collection Platform. In the afternoon, the discussions shifted to refining these technical elements, particularly exploring ways to enhance software interfaces and expand the project’s analytical capabilities. A highlight of the day was the involvement of the Patient Advisory Group, whose feedback reaffirmed the importance of maintaining a patient-centered approach throughout the project.
The second day featured a deep dive into the legal and ethical aspects of AI technology within the context of the TOLIFE project. A dedicated workshop on the EU Artificial Intelligence Act sparked engaging conversations on compliance and the ethical use of AI, helping the team align on best practices and regulatory considerations.
The two-day assembly fostered meaningful dialogue and set clear priorities for the next phases, ensuring that TOLIFE continues to advance in its mission to improve patient outcomes through cutting-edge technology and research.
9 July 2024
The TOLIFE project, aimed at revolutionizing the management of Chronic Obstructive Pulmonary Disease (COPD), has officially commenced its Clinical Study A. This milestone marks a significant step forward in the project’s mission to enhance the quality of life for COPD patients through personalized treatment and advanced technological solutions.
The Role of AI in COPD Management
TOLIFE leverages artificial intelligence (AI) to process daily life patient data captured by unobtrusive sensors. This AI-driven approach is designed to optimize personalized treatment, assess health outcomes, and ultimately improve the quality of life for COPD patients. By predicting and mitigating exacerbations, the TOLIFE platform aims to reduce mortality, enhance health-related quality of life, and lower healthcare costs.
Clinical Study A: A Key Component of TOLIFE
Clinical Study A is a crucial element of the TOLIFE project. The recruitment started in June 2024 and each participant will be monitored for 12 months. This study will focus on registering exacerbations and conducting periodic clinical examinations to provide essential clinical references for the AI tools being developed. The data collected from this study will be instrumental in:
Progress and Next Steps
The Clinical Study A has successfully begun, with all necessary smart sensor kits delivered to Germany and Spain. Patients have started participating in the trial, and the platform is already collecting initial data for analysis. This early data collection is a promising start, indicating that the TOLIFE platform is on track to deliver valuable insights and improvements in COPD management.
By integrating advanced AI technologies with patient care, TOLIFE aspires to set a new standard in managing chronic diseases like COPD. The project’s commitment to enhancing patient outcomes through innovative solutions continues to drive its efforts forward.
Stay tuned for more updates on the progress and findings of Clinical Study A and other initiatives under the TOLIFE project.
26 May 2024
Professor Tognetti, the coordinator of the TOLIFE Project, presented an engaging talk at the renowned Pisa Robotics Festival.
The presentation, titled “Intelligent Sensors and Artificial Intelligence for Managing Complex Chronic Diseases: The TOLIFE Project,” showcased the innovative work being done to transform healthcare management through advanced technology.
The TOLIFE Project aims to clinically validate an artificial intelligence (AI) solution to enable optimized and personalized treatment for patients with complex chronic diseases, with a particular focus on chronic obstructive pulmonary disease (COPD). By analyzing daily patient data captured from non-invasive smart devices (such as smartwatches, smartphones, smart mattress covers, smart shoes, and environmental units), TOLIFE predicts exacerbations, assesses patient health outcomes, and characterizes patient health status.
During the talk, Professor Tognetti provided an in-depth overview of the non-invasive smart devices selected for the TOLIFE clinical studies. The discussion emphasized the data collection framework, the rationale behind selecting each specific sensor, the raw data associated, and the health parameters detected.
The event garnered significant attention, drawing experts and enthusiasts from the fields of robotics and healthcare technology. Positive feedback highlighted the audience’s interest in the potential applications of TOLIFE’s cutting-edge solutions.
Stay updated with more news on the TOLIFE project as we continue to innovate in healthcare technology.
For more information about the festival and other talks, visit the Robotics Festival website here.
21 February 2024
Alessandro Tognetti, professor of Bioengineering at the University of Pisa and Coordinator of the TOLIFE project, recently conducted an interview shedding light on the project’s progress.
Over the past 18 months, the TOLIFE project has achieved significant milestones. The team has focused on developing smart sensors and a data platform to monitor COPD patients’ daily activities. With pre-trials currently underway, the project stands on the cusp of transitioning from laboratory development to real-world application.
Looking ahead, the project aims to implement its developed technology in the field. By utilizing non-invasive sensors and advanced algorithms, the goal is to enhance the quality of care for COPD patients and improve their overall health outcomes.
For more insights into the TOLIFE project and its potential impact, watch the full interview with Professor Alessandro Tognetti.
16 November 2023
We are pleased to inform you that a new article of TOLIFE Project is available online now on Repubblica Firenze – Italian Tech, an italian journal focused on innovative Italian technologies. The article entitled “Sensori nel materasso controllano i pazienti” talks about the sensor devices: the shoes, the smartwatch, the mattress, the spirometer+oximeter, all connected to the smartphone that gathers the data and sends them on the TOLIFE cloud platform.
26 October 2023
On 20-22 October 2023, TOLIFE project was presented at Maker Faire 2023, the European event that facilitates and talks about technological innovation in a simple and accessible way, connecting businesses, Academia, people and ideas. It is a trade fair where industry experts, makers and innovators meet to share their projects with the general public. During the event, Lucia Arcarisi and Carlotta Marinai presented TOLIFE inside the University of Pisa’s booth: a highlight was given to the smart mattress that was presented and tested by the participant. At the end of the event, TOLIFE project received a special mention from the fair organizers based on the innovation the project is bringing to society.
Here’s the pictures of the event.
20 October 2023
We are proud to inform you that our project coordinator, Alessandro Tognetti, took the stage at the SOMIRO project School on Miniaturized and soft robots on 9-12 October 2023, in Marina di Castagneto Carducci (Italy). He presented the innovative technological ideas and devices that are shaping the future of COPD care through the TOLIFE Project.
10 October 2023
On 28-29 September 2023, the TOLIFE project team gathered in Barcelona (Spain) in the COPD innovation capital for the M12 General Assembly meeting. During the meeting our Patient Advisory Board (PAG) have joined the Month 12 TOLIFE meeting to preview and give their feedback on the usage of the sensor devices: the shoes, the smartwatch, the mattress, the spirometer+oximeter,all connected to the smartphone that gatjers the data and sends them on the TOLIFE cloud platform.
Have a look at some pictures of the meeting below!
© 2024 Tolife Project. G.A. 101057103 | All Rights Reserved | Powered by beWarrant S.L.
